Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Peter Kadlec files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Barbara Ryan - $47K in INKT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Peter Kadlec?
Robert Peter Kadlec is a corporate insider of MiNK Therapeutics, Inc. (INKT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Robert Peter Kadlec last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 4 filings going back to 2024.
